Bone-Boosting combo could help women with osteoporosis
NCT ID NCT04467983
First seen Jun 09, 2026 · Last updated Jun 14, 2026 · Updated 1 time
Summary
This study looks at whether adding abaloparatide to the usual denosumab treatment can improve bone density more than denosumab alone in postmenopausal women with osteoporosis. About 70 women who have already had at least four denosumab shots will take part. The goal is to see if the combination leads to stronger bones at the hip and spine after 18 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL OSTEOPOROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital for Special Surgery
New York, New York, 10021, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.